| P2093 | author name string | R Douglas Bruce | |
| | Onyema Ogbuagu | |
| P2860 | cites work | Mobile phone text messaging for promoting adherence to antiretroviral therapy in patients with HIV infection | Q24201026 |
| | Oral substitution treatment of injecting opioid users for prevention of HIV infection | Q24234956 |
| | Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies | Q24597052 |
| | Prevention of HIV-1 infection with early antiretroviral therapy | Q24634688 |
| | Towards universal voluntary HIV testing and counselling: a systematic review and meta-analysis of community-based approaches | Q27021509 |
| | Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group | Q28239283 |
| | HIV surveillance--United States, 1981-2008 | Q28239415 |
| | Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial | Q28292876 |
| | Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada | Q28537704 |
| | Changes in HIV incidence among people who inject drugs in Taiwan following introduction of a harm reduction program: a study of two cohorts | Q28542085 |
| | Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050 | Q28732123 |
| | Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model | Q29305377 |
| | Breaking the silence: setting realistic priorities for AIDS control in less-developed countries. | Q30326978 |
| | Epidemiology of HIV in the United States | Q37853327 |
| | Factors that affect HIV testing and counseling services among heterosexuals in Canada and the United Kingdom: an integrated review | Q37971178 |
| | Antiretroviral therapy for prevention is a combination strategy | Q38078278 |
| | Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda | Q38869763 |
| | Advocating for opioid substitution therapy in Central Asia: much still to be done | Q39220204 |
| | Utilization of health care services in hard-to-reach marginalized HIV-infected individuals | Q39793326 |
| | Tenofovir alafenamide vs. tenofovir disoproxil fumarate in single tablet regimens for initial HIV-1 therapy: a randomized phase 2 study | Q42213339 |
| | Infection with concurrent multiple hepatitis C virus genotypes is associated with faster HIV disease progression | Q42989259 |
| | Wanted: guidelines that doctors will follow | Q43152888 |
| | Virology. A bid to thwart HIV with shot of long-lasting drug | Q43651213 |
| | Lessons from Tanzania on the integration of HIV and tuberculosis treatments into methadone assisted treatment | Q43926648 |
| | Is it time for treatment as prevention among people who inject drugs? | Q44252787 |
| | Effects of nurse-delivered home visits combined with telephone calls on medication adherence and quality of life in HIV-infected heroin users in Hunan of China | Q44412981 |
| | A national study of the relationship of care site HIV specialization to early adoption of highly active antiretroviral therapy. | Q44442113 |
| | Human immunodeficiency virus is (once again) a primary care disease | Q45367109 |
| | Use of community-based, directly observed therapy for HIV infection: lessons learned for treatment of hepatitis C virus infection | Q45497591 |
| | Earlier HIV diagnosis--are mobile services the answer? | Q45891912 |
| | HIV is hyperendemic among men who have sex with men in San Francisco: 10-year trends in HIV incidence, HIV prevalence, sexually transmitted infections and sexual risk behaviour | Q46164749 |
| | Lack of HIV testing and awareness of HIV infection among men who have sex with men, Beijing, China | Q46551069 |
| | Randomized trial of the effects of housing assistance on the health and risk behaviors of homeless and unstably housed people living with HIV. | Q46565009 |
| | Expanded screening for HIV in the United States--an analysis of cost-effectiveness. | Q50756519 |
| | Effectiveness and cost-effectiveness of strategies to expand antiretroviral therapy in St. Petersburg, Russia. | Q51108701 |
| | Rates of antiretroviral resistance among HIV-infected patients with and without a history of injection drug use. | Q53853212 |
| | Rapid assessment and response studies of injection drug use: knowledge gain, capacity building, and intervention development in a multisite study | Q57773716 |
| | Rapid expansion of the health workforce in response to the HIV epidemic | Q80193302 |
| | Prevalence of unprotected anal intercourse among HIV-diagnosed MSM in the United States: a meta-analysis | Q84192096 |
| | Medical costs averted by HIV prevention efforts in the United States, 1991-2006 | Q84583161 |
| | Long-acting HIV drugs advanced to overcome adherence challenge | Q87632781 |
| | Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: A randomized controlled trial | Q30497684 |
| | Putting prevention in their pockets: developing mobile phone-based HIV interventions for black men who have sex with men. | Q30538781 |
| | Emerging technologies for HIV prevention for MSM: what we have learned, and ways forward | Q33439680 |
| | Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco | Q33604727 |
| | Methadone as HIV prevention: high volume methadone sites to decrease HIV incidence rates in resource limited settings | Q33729687 |
| | Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings | Q33780939 |
| | HIV seroprevalence in a sample of Tanzanian intravenous drug users | Q33822369 |
| | Epidemiologic data on young men of color who have sex with men. | Q33944693 |
| | Estimation of HIV incidence in the United States | Q34056420 |
| | HIV risk reduction with buprenorphine-naloxone or methadone: findings from a randomized trial | Q34098066 |
| | Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study | Q34126545 |
| | Directly observed therapy (DOT) for nonadherent HIV-infected youth: lessons learned, challenges ahead | Q34213884 |
| | The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic | Q34554572 |
| | High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa | Q34629087 |
| | Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003-11): a national observational cohort study | Q34645964 |
| | HIV infection: epidemiology, pathogenesis, treatment, and prevention | Q34662270 |
| | A systematic review of HIV interventions for black men who have sex with men (MSM) | Q34790344 |
| | The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection | Q35019915 |
| | Uptake of community-based HIV testing during a multi-disease health campaign in rural Uganda | Q35083366 |
| | Unprotected sex among men who have sex with men living with HIV in Brazil: a cross-sectional study in Rio de Janeiro | Q35151250 |
| | HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study | Q35686969 |
| | Boys must be men, and men must have sex with women: a qualitative CBPR study to explore sexual risk among African American, Latino, and White gay men and MSM. | Q35822119 |
| | Quality of HIV care provided by nurse practitioners, physician assistants, and physicians | Q36313009 |
| | Universal testing and treatment as an HIV prevention strategy: research questions and methods | Q36460647 |
| | Cost-effectiveness of antiretroviral therapy for prevention | Q36486226 |
| | A low-effort, clinic-wide intervention improves attendance for HIV primary care | Q36854029 |
| | HIV counseling and testing and access-to-care needs of populations most-at-risk for HIV in Nigeria | Q36944933 |
| | Systemic barriers accessing HIV treatment among people who inject drugs in Russia: a qualitative study. | Q37224404 |
| | Incentivized recruitment of a population sample to a mobile HIV testing service increases the yield of newly diagnosed cases, including those in need of antiretroviral therapy | Q37240749 |
| | The potential impact of expanding antiretroviral therapy and combination prevention in Vietnam: towards elimination of HIV transmission | Q37271760 |
| | The potential uses of preexposure prophylaxis for HIV prevention among people who inject drugs | Q37284476 |
| | Increasing the acceptability of HIV counseling and testing with three C's: convenience, confidentiality and credibility | Q37448871 |
| | Cost-effectiveness of HIV treatment as prevention in serodiscordant couples | Q37554064 |
| | HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage | Q37699887 |
| P433 | issue | 4 | |
| P921 | main subject | prevention of HIV/AIDS | Q7242372 |
| P304 | page(s) | 505-512 | |
| P577 | publication date | 2014-12-01 | |
| P1433 | published in | Current HIV/AIDS reports | Q26842190 |
| P1476 | title | Reaching the unreached: treatment as prevention as a workable strategy to mitigate HIV and its consequences in high-risk groups | |
| P478 | volume | 11 | |